Carisma Therapeutics Inc. Marketable Securities (Current)
Carisma Therapeutics Inc. had Marketable Securities (Current) of $0 as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2024-04-01
- 2023-12-31: Marketable Securities, Current $0.00.
- 2023-09-30: Marketable Securities, Current $11.01M.
- 2023-06-30: Marketable Securities, Current $40.73M.
- 2023-03-31: Marketable Securities, Current $76.19M.
| Period end | Marketable Securities, Current | Marketable Securities, Current as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-04-01 | |
| 2023-09-30 | $11.01M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $40.73M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $76.19M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $27.80M 10-K · filed 2024-04-01 | $54.37M 10-K · filed 2023-02-28 |
| 2022-09-30 | $106.43M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $69.45M 10-Q/A · filed 2022-08-25 | |
| 2021-12-31 | $0.00 10-K · filed 2023-02-28 |